Literature DB >> 14100884

FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS.

M F OLIVER.   

Abstract

Entities:  

Keywords:  ANDROSTERONE; BUTYRATES; HYPERCHOLESTEREMIA

Mesh:

Substances:

Year:  1963        PMID: 14100884     DOI: 10.1016/s0368-1319(63)80023-x

Source DB:  PubMed          Journal:  J Atheroscler Res        ISSN: 0368-1319


× No keyword cloud information.
  20 in total

1.  THE EFFECT OF CHLOROPHENOXYISOBUTYRIC ACID AND ETHINYL ESTRADIOL ON CHOLESTEROL TURNOVER.

Authors:  P J NESTEL; E Z HIRSCH; E A COUZENS
Journal:  J Clin Invest       Date:  1965-06       Impact factor: 14.808

2.  The clofibrate saga: a retrospective commentary.

Authors:  Michael Oliver
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

3.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

Review 4.  Lipid lowering drugs and hyperlipidaemia.

Authors:  R I Levy; B M Rifking
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Pharmacological control of lipid transport.

Authors:  R Paoletti; L Puglisi
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

Review 6.  Experimental approaches to the prophylaxis and treatment of ischaemic heart disease.

Authors:  J D Fitzgerald
Journal:  Postgrad Med J       Date:  1971-01       Impact factor: 2.401

7.  Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.

Authors:  A M Barrett; J M Thorp
Journal:  Br J Pharmacol Chemother       Date:  1968-02

8.  Effect of atromid-S on fibrinolytic activity in patients with ischaemic heart disease and normal blood cholesterol levels.

Authors:  J M Goodhart; H A Dewar
Journal:  Br Med J       Date:  1966-02-05

9.  Microbodies in experimentally altered cells. V. Histochemical and cytochemical studies on the livers of rats and acatalasemic (Csb) mice treated with CPIB.

Authors:  J Reddy; S Bunyaratvej; D Svoboda
Journal:  Am J Pathol       Date:  1969-09       Impact factor: 4.307

10.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.